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OBJECTIVE—The objective of this study was to examine the risk factors of low/mid-
frequency and high-frequency hearing impairment among a nationally representative sample
of diabetic adults.
RESEARCH DESIGN AND METHODS—Data came from 536 participants, aged 20–69
years,withdiagnosedorundiagnoseddiabeteswhocompletedaudiometrictestingduring1999–
2004 in the National Health and Nutrition Examination Survey (NHANES). We deﬁned hearing
impairment as the pure-tone average .25 dB hearing level of pure-tone thresholds at low/mid-
frequencies (500; 1,000; and 2,000 Hz) and high frequencies (3,000; 4,000; 6,000; and 8,000
Hz) and identiﬁed independent risk factors using logistic regression.
RESULTS—Controlling for age, race/ethnicity, and marital status, odds ratios for associations
withlow/mid-frequencyhearingimpairmentwere2.20(95%CI1.28–3.79)forHDL,40mg/dL
and 3.55 (1.57–8.03) for poor health. Controlling for age, race/ethnicity, sex, and income-to-
poverty ratio, odds ratios for associations with high-frequency hearing impairment were 4.39
(1.26–15.26) for history of coronary heart disease and 4.42 (1.26–15.45) for peripheral neu-
ropathy.
CONCLUSIONS—Low HDL, coronary heart disease, peripheral neuropathy, and having
poorhealtharepotentiallypreventablecorrelatesofhearingimpairmentforpeoplewithdiabetes.
Glycemic control, years since diagnosis, and type of glycemic medication were not associated
with hearing impairment.
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S
ome degree of hearing impairment
affects over two-thirds of diabetic
adults, about twofold higher than
thatofthenondiabeticpopulation(1),yet
little is known about the characteristics of
thoseexperiencingthisdisability.Reports
(2,3) indicating that audiometric hearing
thresholds are correlated with diabetes
complications, poor glycemic control, or
diabetes duration are often not corrobo-
rated (4–6). Although cardiovascular dis-
ease and its risk factors, including
smoking, have been linked to hearing
impairment in the general population
(7,8), these associations are unsubstanti-
ated among people with diabetes. One
investigation (9) of diabetes complica-
tions among a population-based sample
demonstrated that hearing impairment
was associated with nephropathy but
not with retinopathy, diabetes duration,
or hemoglobin A1c (A1C). Thus, the evi-
dence that diabetes severity is associated
withthelikelihoodofhearingimpairment
is inconclusive.
Recent national survey data provide
an opportunity to examine the correlates
of hearing impairment in a representative
sample of diabetic adults. The aim of the
currentstudyistoexaminewhether,among
people with diabetes, hearing impairment
is associated with diabetes duration, insulin
use, glycemic control, cardiovascular dis-
ease risk factors, or the presence of diabetes
complications.
RESEARCH DESIGN AND
METHODS—Data, collected during
1999–2004, came from the National
HealthandNutritionExaminationSurvey
(NHANES), which used a complex, mul-
tistage, probability sample representative
of the civilian, noninstitutionalized U.S.
population. Of 5,418 study participants
aged 20–69 years who were randomly
assigned to audiometric testing, 5,147
(95.0%) completed the audiometric ex-
amination, and of those, 399 reported
diagnosed diabetes when asked the ques-
tion, “Other than during pregnancy (for
women), have you ever been told by a
doctor or health professional that you
have diabetes?” Of the remaining 4,748
participants, 2,116 were randomly as-
signed to a fasting blood draw and were
evaluated for undiagnosed diabetes using
the criterion of a fasting blood glucose
$126 mg/dL. Seventy-ﬁve participants
with undiagnosed diabetes were identi-
ﬁed with fasting blood glucose. Of 4,673
participants not identiﬁed from the inter-
view or fasting blood glucose as having
diabetes, 62 had A1C $6.5% and also
were classiﬁed as having undiagnosed di-
abetes, yielding an analytical sample of
536 individuals with diabetes.
Pure-tone audiometry signals were
presentedtoeachearatvaryingintensities
until the threshold at which the partici-
pant was just able to perceive the tone
was identiﬁed. Air-conduction hearing
thresholds in decibels hearing level (dB
HL) were obtained for each ear at 500;
1,000; 2,000; 3,000; 4,000; 6,000; and
8,000 Hz by trained audiometric techni-
cians using a calibrated Interacoustics
Model AD226 audiometer with study par-
ticipants in a sound-treated booth, which
met the American National Standard Max-
imum Permissible Ambient Noise Levels
for Audiometric Test Rooms (ANSI S3.1-
1991).
Participants were classiﬁed as having
low/mid-frequency hearingimpairment if
the average of the pure-tone thresholds
ccccccccccccccccccccccccccccccccccccccccccccccccc
From the
1Epidemiology and Statistics Program, National Institute on Deafness and Other Communication
Disorders, Bethesda, Maryland; and the 2Diabetes Epidemiology Program, National Institute of Diabetes
and Digestive and Kidney Diseases, Bethesda, Maryland.
Corresponding author: Kathleen E. Bainbridge, bainbridgek@mail.nih.gov.
Received 16 November 2010 and accepted 5 April 2011.
DOI: 10.2337/dc10-2161
© 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited,theuseiseducationalandnotforproﬁt,andtheworkisnotaltered.Seehttp://creativecommons.org/
licenses/by-nc-nd/3.0/ for details.
1540 DIABETES CARE, VOLUME 34, JULY 2011 care.diabetesjournals.org
Epidemiology/Health Services Research
ORIGINAL ARTICLE(hereafter referred to as the pure-tone av-
erage[PTA])measuredat500;1,000;and
2,000Hzineitherearexceeded25dBHL.
If the PTA of thresholds measured at
3,000; 4,000; 6,000; and 8,000 Hz in
either ear exceeded 25 dB HL, participants
were classiﬁed as having high-frequency
hearing impairment. A PTA of at least
25 dB HL is considered to be impairment
of sufﬁcient severity to present difﬁculties
with understanding speech (10). Item-
missing threshold data were considered
asaudiometricnonresponse(tonenotper-
ceived). After verifying that the average
of their available pure-tone thresholds
exceeded 25 dB HL, participants with
audiometric nonresponse within a fre-
quency range were classiﬁed as impaired
for that range. For graphical purposes,
the worse ear was deﬁned as the ear
with the greater PTA of all seven thresh-
olds.
Demographic characteristics, includ-
ing age, race/ethnicity, sex, marital status,
and educational attainment were ob-
tained during interviews. Current smok-
ing status and history of smoking also
were obtained by interview. The income-
to-povertyratiowasdeﬁnedastheratioof
reported total family income to the U.S.
Census Bureau poverty threshold. We
deﬁned leisure-time noise exposure as a
positive response to either of two ques-
tions assessing noise exposure from ﬁre-
arms (outside of work) or other noise
sources, for an average of at least once per
month for a year. Occupational noise
exposure was deﬁned as a history of
loud noise at work that required speaking
in a raised voice to be heard. Coronary
heart disease was deﬁned as a positive
response to any of three questions asking
whether a doctor had told the participant
that they have coronary heart disease,
angina,or had aheart attack.Participants
rated their general health status during a
computer-assisted interview. Questions
about the current use of insulin and oral
agents, and years since diabetes diagno-
sis, were asked of those with diagnosed
diabetes.
Anthropometric and clinical mea-
sures were obtained during physical ex-
aminations that included a blood draw
and clean-catch urine collection (11).
BMIwascalculatedasweightinkilograms
divided by the square of height in meters.
We deﬁned central adiposity as a waist
measurement of $102 cm for men or
$88 cm for women. We deﬁned hyper-
tension as systolic blood pressure $140
mmHg, diastolic blood pressure $90
mmHg,orreportofcurrentantihyperten-
sivemedicationuse.Anklebrachialindex,
the ratio of systolic blood pressure in the
brachial artery to that in the posterior
tibial artery in the right or left ankle, was
measured in participants aged $40years.
We deﬁned peripheral arterial disease as
an ankle brachial index ,0.9. Albumin-
uria was deﬁned as a ratio of urinary al-
bumin to urinary creatinine $30 mg/g.
Monoﬁlament testing was administered
to participants aged 40–69 years. Periph-
eral neuropathy was deﬁned as having at
least one insensate area of six metatarsal
sites tested (three on each foot) using a
standard 10-g monoﬁlament. High cho-
lesterol was deﬁned as total cholesterol
$2 0 0m g / d L ,ap o s i t i v er e s p o n s et oa
question of whether a health professional
had ever told the participant that they
havehigh cholesterol,orreportedcurrent
use of lipid-lowering medications. Low
HDL was deﬁned as HDL ,40 mg/dL.
A1C was assessed by Boronate Afﬁnity
High-Performance Liquid Chromatogra-
phy using Primus CLC330 and Primus
CLC 385 (Primus, Kansas City, MO),
and values were standardized to the
method of the Diabetes Control and
Complications Trial, yielding interassay
coefﬁcientsofvariation,3.0%(12).Sub-
optimal glycemic control was deﬁned as
A1C $7%. Plasma glucose was measured
using a hexokinase enzymatic method
with a coefﬁcient of variation of 1.3–
2.2% (11).
Data analysis
The proportions of our sample with
hearing impairment at high frequencies,
atlow/mid-frequencies,atbothfrequency
ranges, and not hearing-impaired were
computed. Statistical differences in the
distribution of sociodemographic and
anthropometric characteristics, noise ex-
posure, smoking, comorbidities, and
characteristics of diabetes were examined
with t tests (for continuous characteris-
tics) and x
2 tests (for categorical charac-
teristics). For the t test, values for years
since diabetes diagnosis were trans-
formed by taking their natural logarithm
to better approximate the assumption of
normality. The level of signiﬁcance was
a = 0.05. Characteristics independently
associated with a greater prevalence of
low/mid-andhigh-frequencyhearingim-
pairmentwere identiﬁedfromoddsratios
and95%CIswereestimatedusinglogistic
regression. Models tested with peripheral
neuropathy,orperipheralarterialdisease,
were limited to participants aged 40–69
years. Differences in the effects of covari-
atesontheoddsofhearingimpairmentby
whether diabetes was previously diag-
nosed were tested with interaction terms.
Analyses were performed using SAS ver-
sion 9.2 (SAS Institute, Cary, NC) and
SUDAAN version10.0.0 (ResearchTrian-
gleInstitute,ResearchTrianglePark,NC),
incorporating 6-year sample weights,
which accounted for the probabilities of
being assigned to audiometry and/or to
fasting plasma glucose testing.
RESULTS—Two-thirds of subjects
with diabeteshad high-frequency hearing
impairment (Table 1). Twenty-six per-
cent also had low/mid-frequency hearing
impairment. Less than 1% of subjects
with diabetes had a low/mid-frequency
hearing impairment without high-
frequency involvement. Characteristics of
the U.S. population with diabetes (diag-
nosed and undiagnosed), aged 20–69
years, are presented in Table 2 and strati-
ﬁedbylow/mid-andhigh-frequencyhear-
ing impairment. Diabetic subjects with
hearing impairment had a mean age of
56–57 years, which was signiﬁcantlyolder
than those without hearing impairment.
Among those with hearing impairment, a
lesser proportion was non-Hispanic black
orMexicanAmerican.Nosexdifferencesin
Table 1—Prevalence of hearing impairment at high frequencies among the U.S. population
with diabetes (diagnosed or undiagnosed) aged 20–69 years stratiﬁed by hearing impairment
status at low/mid-frequencies, NHANES 1999–2004 (n = 536)
n Weighted prevalence (%)
Hearing-impaired at high frequencies 353 65.5
Hearing-impaired at low/mid-frequencies 134 25.9
Not hearing-impaired at low/mid-frequencies 219 39.6
Not hearing-impaired at high frequencies 183 34.6
Hearing-impaired at low/mid-frequencies 3 0.5
Not hearing-impaired at low/mid-frequencies 180 34.1
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were observed, but there was a markedly
higher percentage of male subjects among
the hearing-impaired at high frequencies.
Diabetic adults with low/mid-frequency
hearing impairment were more likely to
be unmarried and to have less than a high
school education, whereas no signiﬁcant
differences in marital or education status
were found by high-frequency hearing im-
pairment status. We found no signiﬁcant
differencesinthe proportions withhearing
impairmentbyleisuretimeoroccupational
noise exposure.
Among subjects with diabetes, prev-
alence of low HDL was signiﬁcantly
greater in those who were hearing-
impairedatthe low/mid-frequency range,
whereas the prevalence of high total
cholesterol was signiﬁcantly higher in
those who were hearing-impaired at the
high-frequency range. We observed no
differences in hearing impairment by the
prevalence of hypertension or current
smoking status. Coronary heart disease
was twice as prevalent among diabetic
subjects with low/mid-frequency hearing
impairment and over four times as prev-
alent among those with high-frequency
hearing impairment compared with those
without hearing impairment. Comparing
diabetic subjects with high-frequency
hearing impairment to those without
impairment, estimates for mean BMI and
the proportion with central adiposity
were not in the expected direction but
were not signiﬁcantly different (P =0.12).
Peripheral neuropathy was experienced
by 25% and peripheral arterial disease
by 9% of those with high-frequency hear-
ing impairment, about four times the
prevalence of these complications among
thosenotimpaired.Higherprevalencees-
timates of albuminuria were observed
among those with hearing impairment at
both frequency ranges, although this was
statistically signiﬁc a n ta tt h el o w / m i d -
frequency range only. We observed no
difference in the proportion with A1C
$7%. The proportion of subjects with
low/mid-frequency hearing impairment
who reported being in poor health was
over two times that of those without
low/mid-frequency hearing impairment.
Table 2—Sociodemographic, noise exposure, and health characteristics of the U.S. population with diabetes (diagnosed or undiagnosed)
aged 20–69 years stratiﬁed by hearing impairment status at low/mid-frequencies and high frequencies, NHANES 1999–2004 (n = 536)
Low/mid-frequencies*
P
High frequencies†
P Hearing-impaired
Not
hearing-impaired Hearing-impaired
Not
hearing-impaired
n (%) 137 (26.3) 399 (73.7) 353 (65.5) 183 (34.6)
Sociodemographic characteristics
Age (years) 56.9 (1.3) 51.2 (0.7) ,0.001 56.3 (0.7) 46.0 (1.0) ,0.001
Race/ethnicity (%)
Non-Hispanic white 64.3 61.2 67.2 52.2
Non-Hispanic black 7.0 17.0 9.7 23.1
Mexican American 4.9 8.8 6.0 11.2
Other, including multiracial 23.9 13.0 ,0.001 17.1 13.6 0.001
Male sex (%) 58.0 57.0 0.90 67.6 37.7 ,0.001
Unmarried (%) 44.5 29.7 ,0.01 32.3 35.9 0.56
Less than high school education (%) 40.3 26.6 0.04 33.2 24.4 0.09
Income to poverty ratio #1 (%) 22.5 14.6 0.08 16.6 16.3 0.95
N o i s ee x p o s u r e( % )
Leisure-time noise exposure 22.4 24.2 0.72 24.3 22.6 0.72
Occupational noise exposure 39.5 36.4 0.60 41.0 30.3 0.13
Health characteristics
Low HDL (%) 44.5 28.9 0.01 36.6 26.4 0.11
High cholesterol (%) 78.4 71.8 0.26 80.2 60.9 ,0.001
Hypertension (%) 60.4 57.6 0.70 61.9 51.6 0.14
Currently smokes (%) 25.5 24.1 0.82 24.8 23.9 0.88
Coronary heart disease (%) 24.2 11.3 ,0.01 20.3 4.3 ,0.001
BMI (kg/m
2) 33.0 (1.0) 33.0 (0.7) 0.95 32.2 (0.56) 34.6 (1.4) 0.12
Central adiposity (%) 78.6 74.1 0.39 72.3 80.8 0.12
Peripheral neuropathy (%)‡ 22.7 19.1 0.57 25.6 5.8 ,0.001
Peripheral arterial disease (%)‡ 12.1 5.6 0.24 9.2 2.4 0.02
Albuminuria (%) 37.4 24.4 0.04 30.8 22.4 0.11
A1C $7% 44.5 47.1 0.71 46.6 45.8 0.91
Self-reported poor health (%) 17.8 7.6 0.01 11.9 7.2 0.14
For diagnosed diabetes (n = 399)
Years since diagnosis|| 14.3 (1.8) 9.2 (0.8) 0.07 12.4 (1.1) 7.0 (0.8) 0.003
Type of medication (%) 0.08 0.38
Insulin use (with or without oral agents) 36.2 22.0 28.0 21.6
Oral agents only 43.3 55.1 51.6 52.4
None 20.5 22.9 20.5 26.0
Dataaremeans(SE),unlessotherwiseindicated.*PTA(500; 1,000; 2,000 Hz).25dBin eitherear.†PTA(3,000; 4,000; 6,000; 8,000 Hz).25dBineitherear.‡Measuredamong
428 participants aged 40–69 years. ||P value for test of difference in mean log-transformed years since diagnosis.
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Hearing impairment and diabetesAmong 399 participants with diagnosed
diabetes, mean diabetes duration in those
with hearing impairment was 5 years
greater than in those without hearing im-
pairment but was statistically signiﬁcant
only at the high-frequency range. Partic-
ipants with low/mid-frequency hearing
impairment used insulin more frequently
and oral medications less frequently
(marginally signiﬁcant, P = 0.08).
Adjusting for sociodemographic fac-
tors, we found that low HDL levels in-
creased the odds of low/mid-frequency
hearingimpairmentby2.2-fold(Table3).
Those who reported poor health were
over three times as likely to have low/
mid-frequency hearing impairment. Sub-
jects who reported coronary heart disease
or peripheral neuropathy had over four
times the odds of high-frequency hearing
impairment. We found no evidence of ef-
fect modiﬁcation of any covariate by di-
agnosed versus undiagnosed diabetes.
Suboptimal glycemic control, years since
diagnosis, type of glycemic medication,
BMI, and high total cholesterol were not
signiﬁcantly related to hearing impair-
ment at either frequency range. Age-
adjusted mean pure-tone thresholds
from the worse ear are presented by the
presenceorabsenceoflowHDL(Fig.1A),
coronary heart disease (Fig. 1B), periph-
eral neuropathy (Fig. 1C), and poor self-
reported health (Fig. 1D). Subjects with
low HDL and coronary heart disease and
thosewhoreportedpoorhealthhadhigher
thresholds at all frequencies than subjects
withouttheseconditions.Subjectswithpe-
ripheral neuropathy had higher thresholds
at frequencies .1,000 Hz.
CONCLUSIONS—Diabetes-related
hearing loss has been described as a pro-
gressive, sensorineural impairment (5)
affecting audiometric thresholds between
500 and 8,000 Hz (1). Presbycusis, or
age-related hearing loss, typically begins
in the higher frequencies and progresses
tothemiddleandthenlowerfrequenciesas
people age. Correlates of high-frequency
hearing loss may indicate characteristics
of those in an earlier stage of presbycusis,
and subjects who additionally have low/
mid-frequency hearing impairment are
more likely to have had hearing impair-
ment for a longer period of time. Thus,
we evaluated correlates of low/mid- and
high-frequency hearing impairment in a
nationally representative sample of dia-
betic adults aged 20–69 years.
Weobserved strongassociationswith
ageandraceatbothfrequencyrangesthat
are consistent with evidence from the
general population (13). Despite the
higher prevalence of diabetes complica-
tions, such as retinopathy and nephropa-
thy, among non-Hispanic blacks and
MexicanAmericans (14,15),thesegroups
had lower prevalence of hearing impair-
ment compared with non-Hispanic
whites or people from other minority
race/ethnicity groups. The higher odds
of high-frequency hearing impairment
among male subjects than female subjects
ispossiblyattributedtoresidualconfound-
ing by industrial and/or recreational noise
exposure,forwhichself-reportedmeasures
often are inadequate. Excessive noise com-
monly affects hair cells sensitive to signals
of 4,000–6,000 Hz, and elevated thresh-
olds in this range are more commonly ob-
served among male subjects (16). We
observed greater prevalence of high- fre-
quency hearing impairment among those
with a lower income-to-poverty ratio,
consistent with previously described so-
cioeconomic inequalities (17). In addi-
tion to exposure to noisy environmental
conditions (18), subjects of lower socio-
economic status may have a history of in-
adequate glycemic control, for which we
are unable to adjust adequately because
we have only one A1C measurement. We
observed a greater prevalence of low/mid-
frequency hearing impairment among un-
married subjects. Cruickshanks et al. (19)
have reported greater risk of hearing im-
pairment among unmarried subjects over
10 years of follow-up, but the role of mar-
ital status in the development of hearing
impairment remains unknown.
There is debate about whether diabe-
tes affects hearing through angiopathic or
neuropathic mechanisms (20). We found
hearing impairment in the low/mid- and
high-frequency range to be associated
with low HDL and coronary heart disease
history, respectively. These observations
support the hypothesis that diabetes-
related hearing loss accompanies an ath-
erosclerotic mechanism affecting the inner
ear that also may occur subsequent to an
ischemic event. There are no population-
based studies of subjects with diabetes
with which to compare our ﬁndings,
but Gates et al. (7) described elevated
low/mid-frequency pure-tone thresholds
among male subjects (but not female sub-
jects) of the Framingham Cohort Study
with conﬁrmed myocardial infarction
and reported a greater occurrence of low/
mid-frequency hearing impairment among
bothmaleandfemalesubjectswithcon-
ﬁrmed coronary heart disease. Our evi-
dence agrees with observations by Gates
etal.(7)whofoundan inverserelationship
between HDL and low/mid-frequency
PTAamongwomen.Findingsfromastudy
of middle-aged men in military occupa-
tions further support an atherosclerotic
mechanism based on modest associations
ofhightotalcholesterolandhightriglycer-
ides with hearing impairment after adjust-
ing for diabetes (21). It is important to
note that we observed no association be-
tween hearing impairment and albumin-
uria, an outcome related to microvascular
disease. The elevated odds of hearing im-
pairment among non-Hispanic white sub-
jects that we observed compared with
non-Hispanic black or Mexican-American
subjects also is incongruent with usual
race/ethnic patterns of microvascular com-
plications,suchasnephropathyorretinop-
athy (14,15).
We observed a strong association of
high-frequency hearing impairment with
peripheral neuropathy. Diabetic neurop-
athy is a well-established complication of
uncontrolled hyperglycemia, but there is
Table 3—Associations between risk factors for low/mid-frequency and high-frequency
hearing impairment among the U.S. population with diabetes (diagnosed or undiagnosed)
aged 20–69 years (low/mid-frequency model) or aged 40–69 years (high-frequency model)
Low/mid-frequency hearing
impairment*
High-frequency hearing
impairment†
Odds ratio (95% CI)‡ Odds ratio (95% CI)§
n 485 400
Coronary heart disease — 4.39 (1.26–15.26)
HDL ,40 mg/dL 2.20 (1.28–3.79) —
Peripheral neuropathy|| — 4.42 (1.26–15.45)
Self-reported poor health 3.55 (1.57–8.03) —
*PTA(500; 1,000; 2,000 Hz).25dBineitherear.†PTA(3,000; 4,000; 6,000; 8,000 Hz).25dBineitherear.‡Low/mid-
frequencymodel adjustedforage,race/ethnicity,andmaritalstatus.§High-frequency modeladjusted for sex
and income-to-poverty ratio. ||Peripheral neuropathy was measured in individuals aged $40 years.
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Bainbridge, Hoffman, and Cowielittle population-based evidence of a cor-
relation with hearing function despite the
hypotheses that diabetes or hyperglyce-
mia may affect the sensory neurons of the
inner ear, involve the VIII nerve, or in-
ﬂuence central auditory processing
(22,23). Several studies have examined
the effect of diabetic neuropathy on audio-
metric threshold levels with small samples
ofpatientswithtype 1 diabetes, butoverall
evidence is inconclusive as to the indepen-
dent effects of neuropathy, other compli-
cations, diabetes duration, or glycemic
control(2–6).Apreviousepidemiologicin-
vestigation of type 2 diabetes and hearing
impairmentfound noassociationforeither
diabetesdurationorA1C,ﬁndingsthatour
study corroborates (9).
We acknowledge the limitations to
this analysis. Our sample is derived from
noninstitutionalized adults, so we are
unabletogeneralizetosubjectsinnursing
homes, where more severe disability
might be expected. We cannot differenti-
ate subjects with type 1 diabetes from
those with type 2 diabetes, but note that
90–95% of the diabetic adults in our na-
tionallyrepresentativesamplearelikelyto
have type 2 diabetes (24). Temporal rela-
tionships between our covariates and
hearing impairment remain ambiguous
as a result of the cross-sectional nature
ofthedata.Therealsomaybesomeerrors
in the measurement of independent vari-
ables. Years since diabetes diagnosis is an
imperfect proxy for disease duration, par-
ticularly if pathogenic changes accompany
hyperglycemic states prior to diabetes di-
agnosis (25).
In summary, hearing impairment is
not widely recognized as a complication
of diabetes despite its occurrence in as
many as two-thirds of our diabetic sam-
ple. Among U.S. adults with diabetes, we
identiﬁed a greater likelihood of hearing
Figure 1—A: Age-adjusted mean of pure-tone thresholds assessed in the worse ear among U.S. adults aged 20–69 years, by HDL status, NHANES
1999–2004.B:Age-adjustedmeanofpure-tone thresholdsassessedintheworseearamongU.S.adultsaged20–69years,bycoronaryheartdisease
status, NHANES 1999–2004. C: Age-adjusted mean of pure-tone thresholds assessed in the worse ear among U.S. adults aged 40–69 years, by
peripheralneuropathystatus,NHANES1999–2004.D:Age-adjustedmeanofpure-tonethresholdsassessedintheworseearamongU.S.adultsaged
20–69years,byself-reportedhealthstatus,NHANES1999–2004.(Ahigh-qualitycolorrepresentationofthisﬁgureisavailableintheonlineissue.)
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Hearing impairment and diabetesimpairment for those who are older, non-
Hispanic white, male, or who have lower
income. Diabetic subjects with low
HDL, a history of coronary heart disease,
symptoms of peripheral neuropathy, or
those who report poor health also
exhibited a greater likelihood of hearing
impairment. Longitudinal research will
be important in delineating the natural
history of hyperglycemia, diabetes dura-
tion, and the presence of diabetes com-
plications in the occurrence of hearing
impairment.
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